Agenda Day 1 | December 6, 2016

7:30 – 8:15 AM Breakfast & Registration
Welcome
8:15 – 8:25 AM	Anthony J. Sinskey Professor, Department of Biology; Faculty Director, CBI, MIT view bio
Keynote Introductions
8:25 – 8:30 AM	Stacy L. Springs Director, BioMAN; Executive Director, CAACB, CBI, MIT view bio
Keynote Presentations
8:30 – 9:15 AM	Mirrors and Reflections: Perspectives on the Development and Manufacture of Biologic Medicines in the United States Jeffrey C. Baker Deputy Director, Office of Biotechnology Products, CDER, FDA view bio | view abstract
9:15 – 10:00 AM	Next Generation Manufacturing in Biogen’s Hybrid Biomanufacturing Network Jorg Thommes Senior Vice President, Engineering & Technology, Biogen view bio | view abstract
10:00 – 10:15 AM Morning Refreshment Break
Session 1: Current and Emerging Approaches to Manufacturing Biologics
	Session Chair: James C. Leung, Senior Research Fellow, CBI, MIT view bio
10:15 – 10:45 AM	Facility Considerations - Planning for the Future James Bouressa Senior Director, Clinical Manufacturing, Pfizer view bio | view abstract
10:45 – 11:15 AM	Scale-out with Disposable Manufacturing Jie Chen Vice President, CMC Operations, WuXi Biologics view bio | view abstract
11:15 – 11:45 AM	Manufacturing Strategy and Facilities for a Diverse World - Avoiding Facility Obsolescence Parrish M. Galliher Chief Technology Officer, Upstream, GE Healthcare Life Sciences view bio | view abstract
11:45 AM – 12:15 PM	Game of Clones PJ Millan Head of Process Automation, R&D Platform Technology & Science, GlaxoSmithKline view bio | view abstract Christopher Stevens Senior Director, Operations, Planning, and Strategy - Biopharm and Cell & Gene Therapy, GlaxoSmithKline view bio | view abstract
12:15 – 1:15 PM Lunch
Session 2: Innovative Technologies for Manufacturing Traditional Biologics
	Session Chair: Stacy L. Springs, Director, BioMAN; Executive Director, CAACB, CBI, MIT
1:15 – 1:45 PM	Biogen’s Approach to Advanced Process Control in Biomanufacturing Eliana Clark Vice President, Manufacturing Sciences, Biogen view bio | view abstract
1:45 – 2:15 PM	Advanced Process Control Opportunities for Biologics Shekar Ganesa Executive Director, Process Development, Amgen view bio | view abstract
2:15 – 2:45 PM	Upstream Options for Process Intensification: Perfusion, Metabolism Meddling for Growth Inhibitor Control, Hybrid Processes, and Anything Else to Get More Cells for More Stuff Gregory Hiller Associate Research Fellow, Culture Process Development, Pfizer view bio | view abstract
2:45 – 3:15 PM	Advances in Microbioreactor and Analytic Platforms for Bioprocess Support Rajeev Ram Professor, Department of Electrical Engineering and Computer Science, MIT view bio | view abstract
3:15 – 3:45 PM	Sutro’s Cell Free Manufacturing Systems - Platforms Well Suited for the Flexible Manufacture of the Protein Therapeutics of Today and Tomorrow Stuart Bussell Senior Director, Process Development, Sutro Biopharma view bio | view abstract
3:45 – 4:00 PM Afternoon Refreshment Break
4:00 – 4:30 PM	Challenges and Opportunities for Distributed Manufacturing of High-Quality Biopharmaceuticals J. Christopher Love Associate Professor, Department of Chemical Engineering, MIT view bio | view abstract
4:30 – 5:00 PM	Impact of Vaccine Manufacturing Excellence on Global Health Rahul Singhvi Senior Vice President and Chief Operating Officer, Global Vaccine Business Unit, Takeda Pharmaceuticals International view bio | view abstract
5:00 – 5:30 PM	Just Add Water: Portable, On-Demand Biomolecular Manufacturing Peter Nguyen Technology Development Fellow, Laboratory of James Collins, Wyss Institute of Biologically Inspired Engineering, Harvard University view bio | view abstract
5:30 – 6:00 PM	Manufacturing Biologics Using Tobacco Plants Hugh A. Haydon President, Kentucky BioProcessing view bio | view abstract
Closing Remarks
6:00 – 6:05 PM	Stacy L. Springs Director, BioMAN; Executive Director, CAACB, CBI, MIT view bio
6:05 – 7:00 PM Cocktail Reception